プロバイオティクス菌株の世界市場：成長、将来展望、競合分析 (2024年～2032年)

プロバイオティクス菌株市場は、プロバイオティクスの特定菌株の商品化と応用を中心に展開しています。これらの微生物は適切な量を投与されると、宿主に健康上の利益をもたらします。歴史的には、プロバイオティクスは主にヨーグルトやその他の発酵食品に関連していました。しかし、科学的な理解が深まるにつれて、特定の健康問題をターゲットとした特定菌株の分離が急成長市場となっています。プロバイオティクス菌株市場は、健康意識の高まりと用途の拡大により、2024年から2032年にかけてCAGR 7.8%で成長すると推定されます。

市場促進要因：腸の健康に対する意識の高まり

プロバイオティクス菌株市場を促進する主な要因の1つは、全体的な健康状態における腸の健康の重要な役割に対する意識の高まりです。すべての病気は腸から始まる」という格言があります。現代科学はこれをますます支持し、腸の健康は消化器系の疾患だけでなく、精神衛生から免疫系の機能性に至るまで、より広範な健康問題とも関連しています。例えば、Psychopharmacology誌は、乳酸菌やビフィズス菌のようなプロバイオティクス菌株が、気分に直接作用するγ-アミノ酪酸 (GABA) のような神経活性物質を産生・供給できることを示す研究を発表しています。

市場機会：栄養補助食品と化粧品分野での拡大

プロバイオティクス菌株は、栄養補助食品と化粧品分野で急成長しています。人々は健康に対する自然な解決策を求め続けており、その結果、栄養補助食品にプロバイオティクス菌株を取り入れるケースが増えています。さらに、美容・スキンケア業界はもはや単なる美的感覚にとどまらず、肌の健康全般を重視するようになっています。International Journal of Women's Dermatology誌に掲載された論文では、プロバイオティクスがスキンケアにおける潜在的なゲームチェンジャーとなり、にきびから老化まで様々な問題に対処し、市場成長の大きな道をもたらす可能性があることが強調されています。

市場抑制要因：厳しい規制枠組

しかし、プロバイオティクス菌株市場にとってすべてが順風満帆というわけではありません。重要な阻害要因は、健康強調表示を取り巻く規制状況の厳しさです。多くの地域では、製品がプロバイオティクスを含むと表示され、関連する健康上のメリットを謳うためには、厳格な試験と検証プロセスが必要です。例えば、欧州食品安全機関 (EFSA) は、プロバイオティクスに関連する健康強調表示について特に厳しく、エビデンス不足を理由にその多くを却下しています。

市場の課題：菌株の安定性と生存性

規制上の課題だけでなく、プロバイオティクス菌株の安定性と生存性に関する具体的な課題もあります。これらの菌株が、消費者の手に届くまで確実に生存し、効果を発揮し続けることは、並大抵のことではありません。温度、pH、酸素レベルなどの要因が、プロバイオティクス菌株の生存性に劇的な影響を与える可能性があります。The World Journal of Gastroenterology誌が引用しているように、多くの製品が検査された結果、記載されているよりもはるかに少ない生菌しか含まれていなかったり、全く含まれていなかったりすることがあり、最終消費者に強力で効果的な製品を届けるという重要な課題が浮き彫りになっています。

種類別セグメンテーション

プロバイオティクス菌株市場は、乳酸菌、ラクトバチルス・ラムノーズGG、ビフィズス菌などの主要菌株を含むタイプ別に顕著にセグメント化されています。2023年には、ラクトバチルス・アシドフィルスが、主に乳糖不耐症から特定の皮膚疾患まで幅広い症状の治療に応用されるため、収益面で市場を独占しました。しかし、Lactobacillus rhamnoses GGのセグメントが最も高い年間平均成長率 (CAGR) を示しました。この菌株は、特に胃腸感染症や抗生物質関連下痢症など、多くの症状の治療と予防に有効であることがよく調査されているため、支持を集めています。

形状別セグメンテーション

市場を形状別に分析すると、プロバイオティクス市場は乾燥タイプと液体タイプに二分されます。歴史的に見ると、2023年の売上高では乾燥セグメントが大きなシェアを占めています。主にカプセルや粉末状の乾燥プロバイオティクスは、液体と比較して保存期間が長く、保管が容易で輸送の手間がかかりません。しかし、液体タイプは2024年から2032年にかけて顕著なCAGRを記録すると予測されています。この成長は、コンブチャ、ケフィア、プロバイオティック・ショットのような飲用プロバイオティクスの需要が増加していることに起因しています。

地域別洞察

地域的には、北米地域が2023年に最大の収益貢献者に浮上しました。高い認知度、研究開発への多額の投資、確立された栄養補助食品および食品・飲料産業の存在といった要因が、この地域における市場の成功を支えています。とはいえ、アジア太平洋地域は2024年から2032年にかけて最も高いCAGRを記録すると予想されています。可処分所得が増加し、健康とウェルネス製品に対する嗜好が高まっている、急速に都市化する人口を特徴とする中国やインドのような国々における爆発的な成長が、この動向を後押ししています。

競合動向

競合情勢では、Hansen Holding A/S、Probi、Aumgene Bioscience、Virchow Biotech Private Limited、Merck KGaA、I. du Pont de Nemours and Company、Koninklijke DSM N.V.、Ganeden、Lesaffre、Essum AB、Vario Dairy、BioGaia、森永乳業株式会社、スノーボード乳業株式会社、Danone、Kerry Plc、Culturelle、Urex Biotechなどの企業がトップランナーです。2023年、これらの企業は市場の優位性を確保するため、M&Aから大規模な研究開発投資まで幅広い戦略を採用しました。例えば、デュポンによるヘルス・エンハンスメント・プロダクツの買収は、プロバイオティクス分野での地位強化の意図を示すものです。市場プレーヤーはまた、独自の健康効果を持つ新しい菌株を発見するために研究を深く掘り下げており、進化する消費者の需要に応える製品の着実な発売を保証しています。

当レポートでお答えする主な質問

プロバイオティクス菌株市場の成長に影響を与えている主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントと地域に関する主な投資ポケットは？

推定・予測・市場見通し (2032年まで)

予測期間中にCAGRが最も速いセグメントは？

市場シェアの大きいセグメントとその理由は？

中低所得国はプロバイオティクス菌株市場に投資しているか？

プロバイオティクス菌株市場で最大の地域市場はどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と動向は？

プロバイオティクス菌株市場の成長を促進する主要動向は？

世界のプロバイオティクス菌株市場で存在感を高めるための主要な競合企業とその主要戦略とは？

目次

第1章 序文

• 分析内容
  • 分析の目的
  • 対象者
  • 主な提供
• 市場セグメンテーション
• 分析手法
  • フェーズⅠ：二次調査
  • フェーズⅡ：一次調査
  • フェーズⅢ：有識者レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 プロバイオティクス菌株市場：競合分析

• 主要ベンダーの市場ポジショニング
• ベンダーが採用した戦略
• 主要な産業戦略
• ティア分析：2023年 vs 2032年

第4章 プロバイオティクス菌株市場：マクロ分析と市場力学

• イントロダクション
• 世界のプロバイオティクス菌株市場 (金額ベース、2022～2032年)
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
  • サプライヤーパワー
  • バイヤーパワー
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治情勢
  • 経済情勢
  • 技術情勢
  • 法的情勢
  • 社会情勢

第5章 プロバイオティクス菌株市場：種類別 (2022～2032年)

• 市場概要
• 成長・収益分析：2023年 vs 2032年
• 市場セグメンテーション
  • ラクトバチルス・アシドフィルス
  • ラクトバチルス・ラムノセスGG
  • ビフィズス菌
  • その他

第6章 プロバイオティクス菌株市場：形状別 (2022～2032年)

• 市場概要
• 成長・収益分析：2023年 vs 2032年
• 市場セグメンテーション
  • 乾燥
  • 液体

第7章 プロバイオティクス菌株市場：最終用途別 (2022～2032年)

• 市場概要
• 成長・収益分析：2023年 vs 2032年
• 市場セグメンテーション
  • 食品・飲料
  • ヨーグルトドリンク・発酵乳
  • 果汁
  • ベーカリー
  • 肉製品
  • 医薬品
  • 機能性食品
  • 動物飼料
  • 栄養補助食品

第8章 北米のプロバイオティクス菌株市場 (2022～2032年)

• 市場概要
• プロバイオティクス菌株市場：製品別 (2022～2032年)
• プロバイオティクス菌株市場：形状別 (2022～2032年)
• プロバイオティクス菌株市場：最終用途別 (2022～2032年)
• プロバイオティクス菌株市場：地域別 (2022～2032年)
  • 北米
    • 米国
    • カナダ
    • その他北米地域

第9章 英国・EU諸国のプロバイオティクス菌株市場 (2022～2032年)

• 市場概要
• プロバイオティクス菌株市場：製品別 (2022～2032年)
• プロバイオティクス菌株市場：形状別 (2022～2032年)
• プロバイオティクス菌株市場：最終用途別 (2022～2032年)
• プロバイオティクス菌株市場：地域別 (2022～2032年)
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州地域

第10章 アジア太平洋のプロバイオティクス菌株市場 (2022～2032年)

• 市場概要
• プロバイオティクス菌株市場：製品別 (2022～2032年)
• プロバイオティクス菌株市場：形状別 (2022～2032年)
• プロバイオティクス菌株市場：最終用途別 (2022～2032年)
• プロバイオティクス菌株市場：地域別 (2022～2032年)
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第11章 ラテンアメリカのプロバイオティクス菌株市場 (2022～2032年)

• 市場概要
• プロバイオティクス菌株市場：製品別 (2022～2032年)
• プロバイオティクス菌株市場：形状別 (2022～2032年)
• プロバイオティクス菌株市場：最終用途別 (2022～2032年)
• プロバイオティクス菌株市場：地域別 (2022～2032年)
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域

第12章 中東・アフリカのプロバイオティクス菌株市場 (2022～2032年)

• 市場概要
• プロバイオティクス菌株市場：製品別 (2022～2032年)
• プロバイオティクス菌株市場：形状別 (2022～2032年)
• プロバイオティクス菌株市場：最終用途別 (2022～2032年)
• プロバイオティクス菌株市場：地域別 (2022～2032年)
  • 中東・アフリカ
    • 湾岸協力会議 (GCC) 諸国
    • アフリカ
    • その他中東・アフリカ地域

第13章 企業プロファイル

• Hansen Holding A/S
• Probi
• Aumgene Bioscience
• Virchow Biotech Private Limited
• Merck KGaA
• I. du Pont de Nemours and Company
• Koninklijke DSM N.V.
• Ganeden
• Lesaffre
• Essum AB
• Valio Dairy
• BioGaia
• Morinaga Milk Industry Co. Ltd.
• Snow Board Milk Products Co. Ltd.
• Danone
• Kerry Plc
• Culturelle
• Urex Biotech
• その他

List of Tables

• TABLE 1 Global Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 2 Global Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 3 Global Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 4 North America Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 5 North America Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 6 North America Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 7 U.S. Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 8 U.S. Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 9 U.S. Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 10 Canada Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 11 Canada Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 12 Canada Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 13 Rest of North America Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 14 Rest of North America Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 15 Rest of North America Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 16 UK and European Union Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 17 UK and European Union Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 18 UK and European Union Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 19 UK Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 20 UK Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 21 UK Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 22 Germany Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 23 Germany Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 24 Germany Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 25 Spain Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 26 Spain Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 27 Spain Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 28 Italy Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 29 Italy Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 30 Italy Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 31 France Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 32 France Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 33 France Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 34 Rest of Europe Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 35 Rest of Europe Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 36 Rest of Europe Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 37 Asia Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 38 Asia Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 39 Asia Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 40 China Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 41 China Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 42 China Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 43 Japan Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 44 Japan Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 45 Japan Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 46 India Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 47 India Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 48 India Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 49 Australia Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 50 Australia Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 51 Australia Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 52 South Korea Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 53 South Korea Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 54 South Korea Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 55 Latin America Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 56 Latin America Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 57 Latin America Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 58 Brazil Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 59 Brazil Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 60 Brazil Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 61 Mexico Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 62 Mexico Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 63 Mexico Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 64 Rest of Latin America Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 65 Rest of Latin America Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 66 Rest of Latin America Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 67 Middle East and Africa Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 68 Middle East and Africa Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 69 Middle East and Africa Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 70 GCC Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 71 GCC Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 72 GCC Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 73 Africa Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 74 Africa Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 75 Africa Probiotic Strains Market By End-Use, 2022-2032, USD (Million)
• TABLE 76 Rest of Middle East and Africa Probiotic Strains Market By Type, 2022-2032, USD (Million)
• TABLE 77 Rest of Middle East and Africa Probiotic Strains Market By Form, 2022-2032, USD (Million)
• TABLE 78 Rest of Middle East and Africa Probiotic Strains Market By End-Use, 2022-2032, USD (Million)

List of Figures

• FIG. 1 Global Probiotic Strains Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Probiotic Strains Market: Quality Assurance
• FIG. 5 Global Probiotic Strains Market, By Type, 2023
• FIG. 6 Global Probiotic Strains Market, By Form, 2023
• FIG. 7 Global Probiotic Strains Market, By End-Use, 2023
• FIG. 8 Global Probiotic Strains Market, By Geography, 2023
• FIG. 9 Market Geographical Opportunity Matrix - Global Probiotic Strains Market, 2023

FIG. 10Market Positioning of Key Probiotic Strains Market Players, 2023

FIG. 11Global Probiotic Strains Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

• FIG. 12 Global Probiotic Strains Market, By Type, 2023 Vs 2032, %
• FIG. 13 Global Probiotic Strains Market, By Form, 2023 Vs 2032, %
• FIG. 14 Global Probiotic Strains Market, By End-Use, 2023 Vs 2032, %
• FIG. 15 U.S. Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 16 Canada Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 17 Rest of North America Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 18 UK Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 19 Germany Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 20 Spain Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 21 Italy Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 22 France Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 23 Rest of Europe Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 24 China Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 25 Japan Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 26 India Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 27 Australia Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 28 South Korea Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 29 Rest of Asia Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 30 Brazil Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 31 Mexico Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 32 Rest of Latin America Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 33 GCC Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 34 Africa Probiotic Strains Market (US$ Million), 2022 - 2032
• FIG. 35 Rest of Middle East and Africa Probiotic Strains Market (US$ Million), 2022 - 2032

The probiotic strains market revolves around the commercialization and application of specific strains of probiotics. These microorganisms, when administered in adequate amounts, confer health benefits to the host. Historically, probiotics were primarily associated with yogurt and other fermented foods. However, as scientific understanding deepened, the isolation of specific strains to target particular health concerns has become a burgeoning market. Probiotic Strains Market is estimated to grow at a CAGR of 7.8% from 2024 to 2032, driven by rising health consciousness and expanding applications.

Market Driver - Rising Awareness of Gut Health

One of the primary drivers propelling the Probiotic Strains Market is the mounting awareness of the critical role of gut health in overall well-being. There's an adage, 'All diseases begin in the gut.' Modern science increasingly supports this, associating gut health with not only digestive disorders but also with broader health issues, from mental health to immune system functionality. For instance, Psychopharmacology published a study showing that probiotic strains like Lactobacillus and Bifidobacterium can produce and deliver neuroactive substances such as gamma-aminobutyric acid (GABA), which have direct effects on mood.

Market Opportunity - Expansion in Nutraceutical and Cosmetic Sectors

There's a burgeoning opportunity for probiotic strains in the nutraceutical and cosmetic sectors. People are continually seeking natural solutions to health concerns, and as a result, the incorporation of probiotic strains into dietary supplements is on the rise. Furthermore, the beauty and skincare industry is no longer just about aesthetics; it's increasingly about overall skin health. A publication in the International Journal of Women's Dermatology highlighted that probiotics could be potential game-changers in skincare, combating issues from acne to aging, and presenting a massive avenue for market growth.

Market Restraint - Stringent Regulatory Frameworks

However, not everything is smooth sailing for the Probiotic Strains Market. A significant restraint is the stringent regulatory landscape surrounding health claims. In many regions, for a product to be labeled as containing probiotics and to tout associated health benefits, there are rigorous testing and validation processes. The European Food Safety Authority (EFSA), for example, has been particularly strict about health claims related to probiotics, rejecting many due to insufficient evidence.

Market Challenge - Stability and Viability of Strains

Beyond regulatory challenges, there's a tangible challenge related to the stability and viability of probiotic strains. Ensuring that these strains remain alive and effective when reaching the consumer is no small feat. Factors such as temperature, pH, and oxygen levels can dramatically impact the viability of probiotic strains. As cited by The World Journal of Gastroenterology, many products, when tested, contain far fewer live organisms than stated, or sometimes none at all, highlighting the critical challenge of delivering a potent and efficacious product to the end consumer.

Segmentation by Type

The probiotic strains market is prominently segmented by type, with key strains including Lactobacillus acidophilus, Lactobacillus rhamnoses GG, Bifidobacterium bifidum, among others. In 2023, Lactobacillus acidophilus dominated the market in terms of revenue, primarily due to its broad-spectrum application in treating conditions ranging from lactose intolerance to certain skin disorders. However, the Lactobacillus rhamnoses GG segment exhibited the highest Compound Annual Growth Rate (CAGR). This strain has gained traction because of its well-researched benefits and efficacy in treating and preventing a plethora of conditions, notably gastrointestinal infections and antibiotic-associated diarrhea.

Segmentation by Form

On analyzing the market by form, the probiotics market bifurcates into dry and liquid forms. Historically, the dry segment held the lion's share of the revenue in 2023. Dry probiotics, primarily in capsule or powdered forms, offer longer shelf-life, easy storage, and hassle-free transportation compared to their liquid counterparts. However, the liquid form segment is anticipated to witness a remarkable CAGR from 2024 to 2032. This growth can be attributed to the increasing demand for drinkable probiotics like kombucha, kefir, and probiotic shots, driven by consumers' inclination toward ready-to-drink health beverages.

Regional Insights

Geographically, the North American region emerged as the largest revenue contributor in 2023. Factors such as high awareness levels, significant investments in R&D, and the presence of well-established nutraceutical and food & beverage industries underpin the market's success in this region. Nevertheless, the Asia-Pacific region is expected to register the highest CAGR from 2024 to 2032. The explosive growth in countries like China and India, characterized by rapidly urbanizing populations with increasing disposable incomes and a growing penchant for health and wellness products, is driving this trend.

Competitive Trends

In the competitive landscape, companies like Hansen Holding A/S, Probi, Aumgene Bioscience, Virchow Biotech Private Limited, Merck KGaA, I. du Pont de Nemours and Company, Koninklijke DSM N.V., Ganeden, Lesaffre, Essum AB, Valio Dairy, BioGaia, Morinaga Milk Industry Co., Ltd., Snow Board Milk Products Co., Ltd., Danone, Kerry Plc, Culturelle, Urex Biotech are some of the front runners. In 2023, these players adopted strategies ranging from mergers and acquisitions to extensive R&D investments to ensure market dominance. For instance, DuPont's acquisition of Health Enhancement Products signified its intent to bolster its position in the probiotics space. Market players are also delving deep into research to uncover novel strains with unique health benefits, ensuring a steady stream of product launches that cater to evolving consumer demands.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Probiotic Strains market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Probiotic Strains market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Type

• Lactobacillus acidophilus
• Lactobacillus rhamnoses GG
• Bifidobacterium bifidum
• Other

Form

• Dry
• Liquid

End-Use

• Food and Beverages
• Yogurt Drink and Fermented Milk
• Fruit Juice
• Bakery
• Meat Products
• Pharmaceuticals
• Functional Food
• Animal Feed
• Dietary Supplement

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Probiotic Strains market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Probiotic Strains market?

Which is the largest regional market for Probiotic Strains market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Probiotic Strains market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Probiotic Strains market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Probiotic Strains Market
• 2.2. Global Probiotic Strains Market, By Type, 2023 (US$ Million)
• 2.3. Global Probiotic Strains Market, By Form, 2023 (US$ Million)
• 2.4. Global Probiotic Strains Market, By End-Use, 2023 (US$ Million)
• 2.5. Global Probiotic Strains Market, By Geography, 2023 (US$ Million)
• 2.6. Attractive Investment Proposition by Geography, 2023

3. Probiotic Strains Market: Competitive Analysis

• 3.1. Market Positioning of Key Probiotic Strains Market Vendors
• 3.2. Strategies Adopted by Probiotic Strains Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2023 Versus 2032

4. Probiotic Strains Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Probiotic Strains Market Value, 2022 - 2032, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Probiotic Strains Market: By Type, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2032
• 5.3. Market Segmentation
  • 5.3.1. Lactobacillus acidophilus
  • 5.3.2. Lactobacillus rhamnoses GG
  • 5.3.3. Bifidobacterium bifidum
  • 5.3.4. Other

6. Probiotic Strains Market: By Form, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2032
• 6.3. Market Segmentation
  • 6.3.1. Dry
  • 6.3.2. Liquid

7. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. Growth & Revenue Analysis: 2023 Versus 2032
• 7.3. Market Segmentation
  • 7.3.1. Food and Beverages
  • 7.3.2. Yogurt Drink and Fermented Milk
  • 7.3.3. Fruit Juice
  • 7.3.4. Bakery
  • 7.3.5. Meat Products
  • 7.3.6. Pharmaceuticals
  • 7.3.7. Functional Food
  • 7.3.8. Animal Feed
  • 7.3.9. Dietary Supplement

8. North America Probiotic Strains Market, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
• 8.3. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
• 8.4. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
• 8.5.Probiotic Strains Market: By Region, 2022-2032, USD (Million)
  • 8.5.1.North America
    • 8.5.1.1. U.S.
      • 8.5.1.1.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.1.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 8.5.1.1.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 8.5.1.2. Canada
      • 8.5.1.2.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.2.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 8.5.1.2.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 8.5.1.3. Rest of North America
      • 8.5.1.3.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.3.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 8.5.1.3.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

9. UK and European Union Probiotic Strains Market, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
• 9.3. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
• 9.4. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
• 9.5.Probiotic Strains Market: By Region, 2022-2032, USD (Million)
  • 9.5.1.UK and European Union
    • 9.5.1.1. UK
      • 9.5.1.1.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.1.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.1.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 9.5.1.2. Germany
      • 9.5.1.2.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.2.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.2.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 9.5.1.3. Spain
      • 9.5.1.3.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.3.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.3.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 9.5.1.4. Italy
      • 9.5.1.4.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.4.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.4.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 9.5.1.5. France
      • 9.5.1.5.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.5.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.5.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 9.5.1.6. Rest of Europe
      • 9.5.1.6.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.6.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 9.5.1.6.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

10. Asia Pacific Probiotic Strains Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
• 10.3. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
• 10.4. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
• 10.5.Probiotic Strains Market: By Region, 2022-2032, USD (Million)
  • 10.5.1.Asia Pacific
    • 10.5.1.1. China
      • 10.5.1.1.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.1.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.1.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 10.5.1.2. Japan
      • 10.5.1.2.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.2.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.2.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 10.5.1.3. India
      • 10.5.1.3.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.3.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.3.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 10.5.1.4. Australia
      • 10.5.1.4.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.4.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.4.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 10.5.1.5. South Korea
      • 10.5.1.5.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.5.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.5.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 10.5.1.6. Rest of Asia Pacific
      • 10.5.1.6.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.6.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 10.5.1.6.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

11. Latin America Probiotic Strains Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
• 11.3. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
• 11.4. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
• 11.5.Probiotic Strains Market: By Region, 2022-2032, USD (Million)
  • 11.5.1.Latin America
    • 11.5.1.1. Brazil
      • 11.5.1.1.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.1.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 11.5.1.1.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 11.5.1.2. Mexico
      • 11.5.1.2.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.2.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 11.5.1.2.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 11.5.1.3. Rest of Latin America
      • 11.5.1.3.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.3.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 11.5.1.3.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

12. Middle East and Africa Probiotic Strains Market, 2022-2032, USD (Million)

• 12.1. Market Overview
• 12.2. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
• 12.3. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
• 12.4. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
• 12.5.Probiotic Strains Market: By Region, 2022-2032, USD (Million)
  • 12.5.1.Middle East and Africa
    • 12.5.1.1. GCC
      • 12.5.1.1.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.1.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 12.5.1.1.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 12.5.1.2. Africa
      • 12.5.1.2.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.2.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 12.5.1.2.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)
    • 12.5.1.3. Rest of Middle East and Africa
      • 12.5.1.3.1. Probiotic Strains Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.3.2. Probiotic Strains Market: By Form, 2022-2032, USD (Million)
      • 12.5.1.3.3. Probiotic Strains Market: By End-Use, 2022-2032, USD (Million)

13. Company Profile

• 13.1. Hansen Holding A/S
  • 13.1.1. Company Overview
  • 13.1.2. Financial Performance
  • 13.1.3. Product Portfolio
  • 13.1.4. Strategic Initiatives
• 13.2. Probi
  • 13.2.1. Company Overview
  • 13.2.2. Financial Performance
  • 13.2.3. Product Portfolio
  • 13.2.4. Strategic Initiatives
• 13.3. Aumgene Bioscience
  • 13.3.1. Company Overview
  • 13.3.2. Financial Performance
  • 13.3.3. Product Portfolio
  • 13.3.4. Strategic Initiatives
• 13.4. Virchow Biotech Private Limited
  • 13.4.1. Company Overview
  • 13.4.2. Financial Performance
  • 13.4.3. Product Portfolio
  • 13.4.4. Strategic Initiatives
• 13.5. Merck KGaA
  • 13.5.1. Company Overview
  • 13.5.2. Financial Performance
  • 13.5.3. Product Portfolio
  • 13.5.4. Strategic Initiatives
• 13.6. I. du Pont de Nemours and Company
  • 13.6.1. Company Overview
  • 13.6.2. Financial Performance
  • 13.6.3. Product Portfolio
  • 13.6.4. Strategic Initiatives
• 13.7. Koninklijke DSM N.V.
  • 13.7.1. Company Overview
  • 13.7.2. Financial Performance
  • 13.7.3. Product Portfolio
  • 13.7.4. Strategic Initiatives
• 13.8. Ganeden
  • 13.8.1. Company Overview
  • 13.8.2. Financial Performance
  • 13.8.3. Product Portfolio
  • 13.8.4. Strategic Initiatives
• 13.9. Lesaffre
  • 13.9.1. Company Overview
  • 13.9.2. Financial Performance
  • 13.9.3. Product Portfolio
  • 13.9.4. Strategic Initiatives
• 13.10. Essum AB
  • 13.10.1. Company Overview
  • 13.10.2. Financial Performance
  • 13.10.3. Product Portfolio
  • 13.10.4. Strategic Initiatives
• 13.11. Valio Dairy
  • 13.11.1. Company Overview
  • 13.11.2. Financial Performance
  • 13.11.3. Product Portfolio
  • 13.11.4. Strategic Initiatives
• 13.12. BioGaia
  • 13.12.1. Company Overview
  • 13.12.2. Financial Performance
  • 13.12.3. Product Portfolio
  • 13.12.4. Strategic Initiatives
• 13.13. Morinaga Milk Industry Co., Ltd.
  • 13.13.1. Company Overview
  • 13.13.2. Financial Performance
  • 13.13.3. Product Portfolio
  • 13.13.4. Strategic Initiatives
• 13.14. Snow Board Milk Products Co., Ltd.
  • 13.14.1. Company Overview
  • 13.14.2. Financial Performance
  • 13.14.3. Product Portfolio
  • 13.14.4. Strategic Initiatives
• 13.15. Danone
  • 13.15.1. Company Overview
  • 13.15.2. Financial Performance
  • 13.15.3. Product Portfolio
  • 13.15.4. Strategic Initiatives
• 13.16. Kerry Plc
  • 13.16.1. Company Overview
  • 13.16.2. Financial Performance
  • 13.16.3. Product Portfolio
  • 13.16.4. Strategic Initiatives
• 13.17. Culturelle
  • 13.17.1. Company Overview
  • 13.17.2. Financial Performance
  • 13.17.3. Product Portfolio
  • 13.17.4. Strategic Initiatives
• 13.18. Urex Biotech
  • 13.18.1. Company Overview
  • 13.18.2. Financial Performance
  • 13.18.3. Product Portfolio
  • 13.18.4. Strategic Initiatives
• 13.19. Others
  • 13.19.1. Company Overview
  • 13.19.2. Financial Performance
  • 13.19.3. Product Portfolio
  • 13.19.4. Strategic Initiatives